Qiuping Liu

Enhancing the Efficacy of Anti-tumor Immunotherapy by Targeting T cell Metabolism

Xinyun Ji, Qiuping Liu, 2019 .

Identification of an HLA-A*24:02-restricted a -fetoprotein signal peptide-derived antigen and its specific T-cell receptor for T-cell immunotherapy

Jia Hua Cheng, Shi Zhong, Wanli Wu, 2020 .

Development of an affinity-enhanced clinical candidate TCR targeting NY-ESO-1 with optimal potency and high specificity

Siyun Li, Haiping Gong, Kai Zhan, 2022, bioRxiv.

Identification of an HLA‐A*24:02‐restricted α‐fetoprotein signal peptide‐derived antigen and its specific T‐cell receptor for T‐cell immunotherapy

Jia Hua Cheng, Haiping Gong, Shi Zhong, 2019, Immunology.

SAGE1: a Potential Target Antigen for Lung Cancer T-Cell Immunotherapy

Haiping Gong, Shi Zhong, Anan Chen, 2021, Molecular Cancer Therapeutics.